Surgery Doctors in Stockton, CA Accepting Medicare

29 Surgery doctors found. Showing 21 - 29

Eric T. Nguyen, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000

Ilia Gur, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2545 W Hammer Ln, Stockton, CA 95209 Phone: 209-957-7050

Deandrea Sims, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1901 N California St, Stockton, CA 95204 Phone: 209-946-6800    Fax: 209-946-6805

Annette Maria Seiler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4722 Quail Lakes Dr, Suite A, Stockton, CA 95207 Phone: 209-476-0675    Fax: 209-476-9389

Halemane S. Ranganath, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000

Dr. Earl Taylor, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2075 Edgewater Court, Stockton, CA 95204 Phone: 209-466-0678    Fax: 209-466-6544

Dean David Sloan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2545 W Hammer Ln, Stockton, CA 95209 Phone: 209-957-7050

Timothy Bechtel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2800 N California St Ste 6, Stockton, CA 95204 Phone: 209-851-2144    Fax: 209-851-2123

Tarig A Samarkandy, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2545 W Hammer Ln, Stockton, CA 95209 Phone: 209-957-7050

News Archive

Middlemen take home almost 53% of the net proceeds from insulin sales, finds study

Despite its discovery nearly 100 years ago, insulin's list price has been going up, not down, with trade secrets and other protections preventing researchers from pinpointing who is receiving profits from its sale.

FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC

The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.

Boston Medical Center receives $3.7 million grant to expand fellowship programs in addiction

Boston Medical Center's Grayken Center for Addiction has received a five-year, $3.7 million grant from the Health Resources and Services Administration to expand its fellowship programs in addiction medicine and addiction psychiatry.

DSM Biomedical, CID partner on use of ComfortCoat Hydrophilic coating technology

DSM Biomedical, a global leader in biomedical materials science, today announced the extension of its partnership with CID based on the use of DSM ComfortCoat® Hydrophilic coating technology on the Optima Jet Stent Delivery System and the Fluydo PTCA Balloon Catheter, both with CE marked and launched on the European market last month.

New technology can help create assistive robots ideally suited for health care sector

Robots carry out their tasks more safely if they are controlled by another technology. This makes them much more suitable for use in the care sector, as revealed by a study conducted at the Robotics and Mechatronics department at the University of Twente. On 2 June, researcher Stefan Groothuis is being awarded his PhD for this work.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)